Changes of microRNA Expression in Obstructive and Neurogenic Bladder Dysfunction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-06-30

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with obstructive or neurogenic lower urinary tract disease will be invited to participate. Upon agreement they will undergo an assessment of bladder function (questionnaires) and bladder biopsies at 2 time-points. Bladder biopsies will be evaluated for molecular changes in the laboratory and compared to the functional findings.By uncovering the molecular similarities and differences between BLUTD and NLUTD, the investigators will elucidate some of the causative factors in the development of these disorders and highlight the impact of myogenic and neurogenic components postulated to be involved. The project involves close collaboration between clinical and basic research.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Long-term Urodynamics in Individuals With Neurogenic Lower Urinary Tract Dysfunction

NCT02443870

Neurogenic Lower Urinary Tract Dysfunction

COMPLETED

Quality, Cost and Treatment Success on Patients With Lower Urinary Tract Dysfunction Undergoing Urodynamic Examination

NCT05809154

Urodynamics Lower Urinary Tract Symptoms Neurogenic Bladder

WITHDRAWN

Health-related Quality of Life of Patients With Neurogenic Bladder

NCT02179073

Neurogenic Bladder Dysfunction

COMPLETED

An Exploratory Study to Investigate Bladder Contractions in the Storage Phase and Related Bladder Sensations in Healthy Females and Females With Overactive Bladder (OAB) Using High Resolution and Conventional Urodynamics

NCT01540786

Healthy Subjects Overactive Bladder

TERMINATED PHASE1

Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord Injury

NCT01601041

Urinary Tract Infection

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Lower urinary tract dysfunction (LUTD) has multiple causes including bladder outlet obstruction (BOO) as a result of benign prostatic hyperplasia (BPH) and neurological diseases including spinal cord injury (SCI). Manifestations of LUTD include storage symptoms such as increased daytime frequency, nocturia, urgency and urinary incontinence and voiding symptoms such as slow stream, hesitancy and incomplete emptying. The consequences of both BOO-induced (BLUTD) and neurogenic LUTD (NLUTD), leading to functional entities including the low compliance high pressure bladder as well as the acontractile high volume low pressure bladder, are believed to share some pathogenetic mechanisms.

In a previous project, the investigators have established micro ribonucleic acid (miRNA) and messenger ribonucleic acid (mRNA) expression profiles of several urodynamically defined states of BLUTD. In this follow-up project, the investigators propose to extend these studies, undertaking a comparative miRNA and RNA profiling of BLUTD and NLUTD, and investigate the dynamic alteration of microRNA expression in different functional manifestations of disease. The investigators propose to validate primary gene targets of miRNAs differentially expressed in urodynamically defined states of BLUTD and identify signaling pathways, activated during the progression from hypertrophy to decompensation. Monitoring the reversal of changes in miRNA expression after relief of obstruction and restoration of normal bladder function will help delineate the key BOO-induced miRNAs with regulatory potential. Similarly, the dynamics of miRNA alteration, observed in SCI patients during the development and management of NLUTD should reveal the role of miRNA in gene expression regulation during neurogenic-induced organ remodelling.

By uncovering the molecular similarities and differences between BLUTD and NLUTD, the investigators will elucidate some of the causative factors in the development of these disorders and highlight the impact of myogenic and neurogenic components postulated to be involved. The project involves close collaboration between clinical and basic research, and combines the analysis of human biopsy material with in vitro cell-based assays, creating a comprehensive platform for the dissection of molecular mechanisms of LUTD. This project will keep the momentum of the investigators' previous research and contribute to the basic and applied studies into bladder remodeling. It is a logical continuation of their on-going studies of the role of miRNAs in LUT disorders but represents a novel direction of research and has high diagnostic and therapeutic potential.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disorder of the Lower Urinary Tract

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Controls

No lower urinary tract symptoms undergoing cystoscopy in anesthesia for stone treatment or microhematuria assessment.

Bladder biopsy

Intervention Type PROCEDURE

Small biopsy of the bladder is taken with cold-cup tongs.

Spinal cord injury/acontractile

Patients with traumatic spinal cord injury (SCI) with no (neither spontaneous nor provoked) detrusor activity during the filling phase of urodynamics.

Bladder biopsy 6 weeks after trauma 6 months later urodynamic study and bladder biopsy

Bladder biopsy

Intervention Type PROCEDURE

Small biopsy of the bladder is taken with cold-cup tongs.

Urodynamic study

Intervention Type PROCEDURE

Assessment of bladder function through intravesical and intrabdominal pressure measurements according to International Continence Society standards.

Spinal cord injury/Detrusor overactivity

SCI patients with proven detrusor (urodynamics) overactivity during the filling phase.

Bladder biopsy 6 weeks after trauma 6 months later urodynamic study and bladder biopsy

Bladder biopsy

Intervention Type PROCEDURE

Small biopsy of the bladder is taken with cold-cup tongs.

Urodynamic study

Intervention Type PROCEDURE

Assessment of bladder function through intravesical and intrabdominal pressure measurements according to International Continence Society standards.

Prostatic obstruction/acontractile

Low flow to no flow, no measurable detrusor activity on urodynamic evaluation, cystoscopy in line with obstruction.

Bladder biopsy at TURP (transurethral resection prostate) 3 months later urodynamic study and bladder biopsy

Bladder biopsy

Intervention Type PROCEDURE

Small biopsy of the bladder is taken with cold-cup tongs.

Urodynamic study

Intervention Type PROCEDURE

Assessment of bladder function through intravesical and intrabdominal pressure measurements according to International Continence Society standards.

Prostatic obstruction/ obstructed

Obstruction according to Schäfer nomogram on urodynamic evaluation. Bladder biopsy at TURP 3 months later urodynamic study and bladder biopsy

Bladder biopsy

Intervention Type PROCEDURE

Small biopsy of the bladder is taken with cold-cup tongs.

Urodynamic study

Intervention Type PROCEDURE

Assessment of bladder function through intravesical and intrabdominal pressure measurements according to International Continence Society standards.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bladder biopsy

Small biopsy of the bladder is taken with cold-cup tongs.

Intervention Type PROCEDURE

Urodynamic study

Assessment of bladder function through intravesical and intrabdominal pressure measurements according to International Continence Society standards.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Planned cystoscopy in anesthesia for upper tract stone treatment or microscopic hematuria evaluation (controls)
* Planned TURP (transurethral prostate resection) (BLUTD)
* Spinal cord injury (in last 6 weeks) (NLUTD)
* Prior urodynamic study
* Informed consent